Kane Biotech Inc (TSXV:KNE)
C$ 0.13 0 (0%) Market Cap: 17.23 Mil Enterprise Value: 18.60 Mil PE Ratio: 4.33 PB Ratio: 0 GF Score: 37/100

Q2 2022 Kane Biotech Inc Earnings Call Transcript

Aug 25, 2022 / 08:30PM GMT
Release Date Price: C$0.11 (-4.35%)
Operator

Good day, and thank you for standing by. Welcome to the Kane Biotech Q2 2022 Financial Results Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Nicole Sendey, Investor Relations and Public Relations for Kane Biotech.

Nicole Sendey
Kane Biotech, Inc. - IR & Public Relations

Thank you, Operator. Good afternoon and welcome, everyone, to Kane Biotech's quarterly 3arnings conference call. We are grateful to have you join us today. This call will cover Kane's financial and operating results for the second quarter of 2022, along with a discussion of some of our recent highlights and goals for 2022 and beyond. Following our prepared remarks, we will open the conference call to a question-and-answer session. Our call today will be led by Kane's Chief Executive Officer, Marc Edwards.

Before we begin our formal remarks, I would like to remind everyone that some of the statements on this conference call contain certain forward-looking information and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot